Compare Acadia Healthcare Company Inc (ACHC) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Acadia Healthcare Company Inc vs Target Corporation — how do they compare? Acadia Healthcare Company Inc trades at $31.93 (market cap $2.90B), while Target Corporation trades at $153.24 (market cap $69.17B). The key difference: Target Corporation is far larger — about 23.9× Acadia Healthcare Company Inc's market cap, and Target Corporation pays a 3.05% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | TGT | |
|---|---|---|
Market Cap | $2.90B | $69.17B |
Sector | Health | Consumer Cyclical |
52-Week High | $35.61 | $152.35 |
52-Week Low | $11.68 | $83.68 |
Enterprise Value | $5.29B | $84.47B |
Dividend Yield | — | 3.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ACHC trades at $31.14, down 2.01% today, with a neutral technical signal and mixed fundamentals. The company reported Q2 2026 EPS of $0.38, beating estimates, but maintains a net loss of -$1.10B for 2025. Analyst consensus is bullish with a $36.00 price target, though ongoing legal investigations and negative profit margins present headwinds. Cash flow from operations improved to $211M in 2026, supporting operational stability amid challenges.
The outlook for ACHC hinges on execution of its turnaround strategy and resolution of legal issues. Upside potential exists if EBITDA guidance improvements and admissions growth persist, but risks from litigation and sustained losses warrant caution. The stock's current valuation at a P/E of 19.82 and P/S of 0.84 may attract value investors if profitability recovers.
Target (TGT) trades at $152.09, up 1.6% today and near its 52-week high, with a bullish technical outlook supported by moving averages. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results pending. Valuation metrics show a P/E of 20.12 and P/S of 0.65, while profitability remains solid with a 22.02% ROE. Recent news highlights the appointment of a Chief AI Officer, signaling strategic focus on technology.
The outlook for TGT is positive, driven by earnings momentum and AI initiatives, but risks include competitive retail pressures and potential margin compression. Analyst consensus is mixed with a $147.72 price target, suggesting limited upside from current levels, though institutional buying activity supports bullish sentiment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Acadia Healthcare Company Inc
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
